Endolaser for treating rosacea: Case report
International Journal of Development Research
Endolaser for treating rosacea: Case report
Received 18th April, 2023; Received in revised form 26th April, 2023; Accepted 14th May, 2023; Published online 30th June, 2023
Copyright©2023, Fábio dos Santos Borges et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction: Rosacea is a chronic inflammatory skin disease characterized by persistent facial redness, telangiectasias, papules/pustules and skin lesions. Endolaser technique (also known as Endolift) uses a laser beam with a wavelength of 980 or 1470nm emitted through an optical fiber inserted into the subcutaneous tissue in order to tone the skin through neocollagenesis and/or reduce subcutaneous fat. Objective: This study aimed to report three cases of rosacea treatment using the endolaser with a wavelength of 980 nm. Methodology: Three cases of rosacea affecting the face of women who used the endolaser as the main treatment resource were reported. The procedure consisted of the application of a laser emitted through a 600 micron fiber optic, directed subdermally to treat dilated blood vessels and reduce the inflammation associated with rosacea. Each patient received a single treatment session. Results: In the reported cases, patients initially reassessed 30 days after the procedure, it was found a satisfactory decrease in rosacea, and free of intercurrences or complications. In the final reassessment, 8 weeks after the procedure, it was confirmed that there was no recurrence of the condition in this period and the final result remained extremely satisfactory. Conclusion: Finally, it is possible to conclude that the endolaser technique is effective for treating rosacea, showing itself as an innovative procedure, once through its photothermal action it has a great power of anti-inflammatory action, strongly contributing to the remission of clinical condition, and can also be associated with other therapeutic resources when there is another joint condition.